End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.29 SEK | -1.02% |
|
-9.52% | -8.81% |
Jul. 08 | Dicot Pharma Files Application for Phase 2a Trial of Erectile Dysfunction Drug | MT |
Jul. 08 | Dicot Pharma Announces Clinical Trial Application for Phase 2A Trial | CI |
Business Summary
Number of employees: 3
Managers
Managers | Title | Age | Since |
---|---|---|---|
Elin Trampe
CEO | Chief Executive Officer | - | 21-08-31 |
Björn Petersson
DFI | Director of Finance/CFO | 63 | 22-03-06 |
Chief Tech/Sci/R&D Officer | 53 | 22-07-10 | |
Mats Silvander
CTO | Chief Tech/Sci/R&D Officer | - | 22-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Zell
BRD | Director/Board Member | - | 21-12-31 |
Director/Board Member | 79 | 22-12-31 | |
Director/Board Member | 68 | 21-05-26 | |
Director/Board Member | 70 | 21-12-31 | |
Chairman | 62 | 20-11-18 | |
Director/Board Member | 71 | 18-04-15 | |
62 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 817,561,834 | 0 | 0 | - |
Company contact information
![address Dicot Pharma AB(DICOT)](https://cdn.zonebourse.com/static/address/120974850.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-8.81% | 22.51M | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+17.90% | 228B | |
+14.86% | 177B | |
+0.45% | 164B |
- Stock Market
- Equities
- DICOT Stock
- Company Dicot Pharma AB